Researchers Receive More than $6 Million to Study Diabetes-Related Cardiovascular Disease Over the past two decades, the number of new diabetes cases has almost tripled in the United States, and 80% of patients with Type 2 diabetes die from cardiovascular disease. Read more...
Cell-Based Immunotherapy Shows Promise Against Melanoma An immunotherapy based on supercharging the immune system’s natural killer cells has been effective in treating patients with recurrent leukemia and other difficult to treat blood cancers. Now, researchers at Washington University School of Medicine in St. Louis have shown in preclinical studies conducted
NextGen Offers New Possibilities for MU Researchers Addressing Health Disparities Loren Bauerband, an assistant professor in the Department of Health Sciences in the University of Missouri School of Health Professions, uses large data sets gathered from many sources — often called big data — to research health disparities facing transgender
Breakthrough Could Lead to Early Detection of Pregnancy Complications The quest to create safer, more successful pregnancies is one of the top goals of modern science. While pregnancy is better understood today than ever before, with improvements in technology helping to lower the risk of negative outcomes, there is much
In Lab, SLU Researchers Find Benefits for Diabetes, Fatty Liver Disease When Combining Two Anti-Diabetes Drugs
In Lab, SLU Researchers Find Benefits for Diabetes, Fatty Liver Disease When Combining Two Anti-Diabetes Drugs A Saint Louis University research team, led by Kyle S. McCommis, Ph.D., assistant professor in Biochemistry and Molecular Biology, found that combining two classes of anti-diabetes drugs provides superior benefits in mouse models of
Newly Approved Drug Effective Against Lung Cancer Caused by Genetic Mutation The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed to
More Insight on Which Kids Are Most at Risk for Severe COVID-19 Certain underlying medical conditions, as well as complex chronic illnesses exacerbated the risk for severe COVID-19 in children, researchers found in a cross-sectional study. Read more...
Laughing Gas Relieves Symptoms in People with Treatment-Resistant Depression A single, one-hour treatment that involves breathing in a mixture of oxygen and nitrous oxide — otherwise known as laughing gas — significantly improved symptoms in people with treatment-resistant depression, according to new data from researchers at Washington University School of
How Saint Louis University's Dr. Daniel Hoft Became One of the Nation's Leading Vaccine Experts Dr. Daniel Hoft is the director of the Saint Louis University Center for Vaccine Development, one of only 10 National Institutes of Health-funded Vaccine Treatment Evaluation Units in the country. During the pandemic, the Columbia,
Stroke-Recovery Device Using Brain-Computer Interface Receives FDA Market Authorization A first-of-its kind device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds has received market authorization from the Food and Drug Administration (FDA). The IpsiHand Upper Extremity Rehabilitation System, developed